Cargando…

Lymph node staging systems in patients with gastric cancer treated with D2 resection plus adjuvant chemotherapy

Background: The optimal nodal staging scheme for gastric cancer remains unsettled. We compared the prognostic performances of the metastatic lymph node, lymph node ratio, and log odds of metastatic lymph nodes based on nomograms among 801 patients with D2-resected gastric cancer treated with adjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yi-Xin, Yang, Lu-Ping, Wang, Zi-Xian, He, Ming-Ming, Yun, Jing-Ping, Zhang, Dong-Sheng, Wang, Feng, Xu, Rui-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858487/ https://www.ncbi.nlm.nih.gov/pubmed/29556323 http://dx.doi.org/10.7150/jca.22016

Ejemplares similares

The role of adjuvant chemotherapy for patients with stage II and stage III gastric adenocarcinoma after surgery plus D2 lymph node dissection: a real-world observation
por: Chiu, Chang-Fang, et al.
Publicado: (2016)

Nodes staging score to quantify lymph nodes for examination in gastric cancer
por: Sun, Liping, et al.
Publicado: (2020)

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
por: Shin, Kabsoo, et al.
Publicado: (2019)

Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma
por: Zhu, Xiaoke, et al.
Publicado: (2020)

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
por: Yu, Yuanyuan, et al.
Publicado: (2021)

Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer
por: Qu, Jing-lei, et al.
Publicado: (2013)

Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients
por: Chen, Yong-He, et al.
Publicado: (2021)

Update of Adjuvant Chemotherapy for Resected Gastric Cancer
por: Oh, Sang Cheul
Publicado: (2012)

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
por: Yang, Lu-Ping, et al.
Publicado: (2019)

Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols
por: Yu, Jeong Il, et al.
Publicado: (2019)

Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy
por: Cheng, Feng-Chou, et al.
Publicado: (2022)

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
por: You, Min Su, et al.
Publicado: (2019)

Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer
por: Chu, Xiaoyuan, et al.
Publicado: (2015)

Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
por: Xing, Jiazhang, et al.
Publicado: (2021)

Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection
por: Ke, Bin, et al.
Publicado: (2014)

Impact of the Number of Dissected Lymph Nodes on Survival for Gastric Cancer after Distal Subtotal Gastrectomy
por: Huang, Chang-Ming, et al.
Publicado: (2011)

Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.
por: Neri, B., et al.
Publicado: (1996)

Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer
por: Yuan, Shu-Qiang, et al.
Publicado: (2017)

The Tumor-Log Odds of Positive Lymph Nodes-Metastasis Staging System, a Promising New Staging System for Gastric Cancer after D2 Resection in China
por: Qiu, Miao-zhen, et al.
Publicado: (2012)

Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy
por: Boström, Peter J., et al.
Publicado: (2016)

Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer
por: Chen, Yi-Fu, et al.
Publicado: (2023)

Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma
por: Tang, Yihui, et al.
Publicado: (2021)

Radiotherapy Combined with Chemotherapy for Regional Lymph Node Recurrence in Gastric Cancer
por: Cai, Liang, et al.
Publicado: (2020)

Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
por: Tominaga, Tetsuro, et al.
Publicado: (2016)

The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy
por: Sakin, Abdullah, et al.
Publicado: (2021)

Alternative staging of regional lymph nodes in gastric cancer
por: Szczepanik, Antoni M., et al.
Publicado: (2016)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients
por: Su, Jian-wei, et al.
Publicado: (2022)

Higher Risk of Lymph Node Metastasis in Young Patients with Early Gastric Cancer
por: Wang, Zu-Kai, et al.
Publicado: (2019)

Coexistence of Perineural Invasion and Lymph Node Metastases Is a Poor Prognostic Factor in Patients with Locally Advanced Rectal Cancer after Preoperative Chemoradiotherapy Followed by Radical Resection and Adjuvant Chemotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2014)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
por: Zhang, Liangze, et al.
Publicado: (2017)

An unresectable gastric cancer with bulky lymph node metastases treated with SOX chemotherapy plus apatinib followed by D3 radical gastrectomy: a case report
por: Zhang, Nannan, et al.
Publicado: (2021)

Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes
por: Chen, Shangxiang, et al.
Publicado: (2017)

Positive lymph node ratio is an index in predicting prognosis for remnant gastric cancer with insufficient retrieved lymph node in R0 resection
por: Wang, Honghu, et al.
Publicado: (2021)

Comparison of prognostic nomograms based on different nodal staging systems in patients with resected gastric cancer
por: Wang, Zi-Xian, et al.
Publicado: (2017)

Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022)

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
por: Chen, Ping, et al.
Publicado: (2022)

Association between adjuvant chemotherapy and survival in stage I gastric cancer patients after curative resection
por: Chen, Qiuying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9kjrsc9iufa95tmdpttqc5dt78